The collaboration will develop the consumable for Proteus that will enable simultaneous large factor, protein sequencing with much improved levels of accuracy.
The two companies began partnering in 2021 on the first-generation Platinum platform and have announced the transition to support production in the second quarter of 2024. SkyWater will continue to supply the consumables for the Platinum Pro product as the two companies expand their engagement to support the commercialisation of Proteus.
This solution looks set to redefine proteomics with unprecedented output per sample, application flexibility and automation.
By combining Quantum-Si’s expertise in biotechnology with SkyWater’s Technology as a Service (TaaS) manufacturing capabilities, the collaboration will help to drive significant advancements in protein sequencing and to the field of proteomics.
"We’re pleased to build on past success together and move into this next product development program with momentum to drive the innovations for this revolutionary proteomics platform," said Ross Miller, SVP Commercial and A&D Business, SkyWater Technology.
"We are excited to expand our relationship with SkyWater around Platinum, and to apply the learnings and their unique capabilities to our next platform innovation," said Jeff Hawkins, President and CEO of Quantum-Si. "With Platinum, we were the first to bring Next-Generation Protein Sequencing to researchers globally and we believe our new technology will enable us to further extend our leadership position in protein sequencing and allow us to extend our technology into other areas of proteomics.”
By leveraging its custom process development and manufacturing capabilities, SkyWater can support the technological needs of microfluidic biomedical devices from proof of concept to final qualification.
By embracing a TaaS model, SkyWater can also support early collaboration with system engineers and device designers, developing technology within a production environment. This approach helps to speed time-to-market, ensuring quality from inception, and scales to meet volume production demands.
SkyWater holds certification to the ISO 13485 Quality Standard for Medical Devices, affirming its ability to support the design, development, and fabrication of biomedical applications.
